TherapeuticsMD, Inc. Research And Development Expense

Quick Answer

TherapeuticsMD, Inc. reported Research And Development Expense of $7.09 million for the year ending 2021.

  • TherapeuticsMD, Inc. showed a decrease of -32.1% in Research And Development Expense from 2020 to 2021.
  • This data is from TherapeuticsMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2022.
  • XBRL data for this metric is available from 2011 to 2021 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2011 to 2021), TherapeuticsMD, Inc.'s Research And Development Expense has grown by 6,507.5%.
  • Historical annual values: Fiscal year 2021: $7.09 million | Fiscal year 2020: $10.43 million | Fiscal year 2019: $19.79 million | Fiscal year 2018: $27.30 million | Fiscal year 2017: $33.85 million | Fiscal year 2016: $53.94 million | Fiscal year 2015: $72.04 million | Fiscal year 2014: $43.22 million | Fiscal year 2013: $13.55 million | Fiscal year 2012: $4.49 million | Fiscal year 2011: $107.2 thousand.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: